Chris Reidy May 23, 2013 Spyros Artavanis-Tsakonas, HMS professor of cell biology, has been appointed to the post of chief scientific officer of Biogen Idec Inc., the Weston biotechnology company perhaps best known for its multiple sclerosis drugs announced. Read full article
The Economic Forces That Drive Prescription Drug Prices October 30, 2025 Luca Maini on what new U.S. policies could mean for patients and health systems
HMS Announces Blavatnik Institute Early Career Investigator Awards November 6, 2025 10 projects receive basic and translational research funding
CTE Is Caused by More Than Head Trauma, New Study Suggests October 30, 2025 Research reveals Alzheimer’s disease-like DNA damage, hints at immune involvement
